Showing results (71-80 of 125) with videos related to
Sort By:
Pageof 13
Experimental Hematology|February 1, 1996
Response of human multiple myeloma-derived cell lines to alkyl-lysophospholipidL Glasser, W S Dalton, R L Fiederlein, et al.Cancer Treatment Reports|November 1, 1983
Amsacrine in refractory adult acute leukemia: a pilot study of the Southeastern Cancer Study GroupE F Winton, E B Hearn, W R Vogler, et al.Blood|August 1, 1977
Slide chamber culture system for the in vitro study of humoral regulation of granulocyte and monocyte-macrophage proliferation and differentiationE F Winton, W R Vogler, K L Kellar, et al.Cancer Research|June 1, 1984
Abnormal profile of serum proteinase inhibitors in cancer patientsR K Chawla, D J Rausch, F W Miller, et al.Lipids|June 1, 1993
Structure-function relationships of alkyl-lysophospholipid analogs in selective antitumor activityW R Vogler, A C Olson, J Hajdu, et al.The American Journal of the Medical Sciences|May 1, 1989
Factors affecting survival in allogeneic bone marrow transplantationW R Vogler, E F Winton, R C Reynolds, et al.Biochemical Pharmacology|January 1, 1984
Phospholipid-sensitive Ca2+-dependent protein kinase inhibition by R-24571, a calmodulin antagonistG J Mazzei, R C Schatzman, R S Turner, et al.Bone Marrow Transplantation|September 1, 1989
Preclinical studies on deoxycoformycin and deoxyadenosine as pharmacologic T cell purging toolsW Sheridan, D S Gordon, A J Fullen, et al.Experimental Hematology|August 1, 1984
The effect of alkyl-lysophospholipids on tritiated thymidine incorporation and clonogenicity in vitro of normal and leukemic human cellsW R Vogler, E A Whigham, L B Somberg, et al.Cancer|April 15, 1982
Treatment of acute myelogenous leukemia: influence of three induction regimens and maintenance with chemotherapy or BCG immunotherapyG A Omura, W R Vogler, J Lefante, et al.Pageof 13